James B. Renacci sold Regeneron Pharmaceuticals Inc (NASDAQ: REGN)
James B. Renacci (R-OH), a U.S. Representative, has disclosed 13 trades in Regeneron Pharmaceuticals Inc (REGN) since 2015, 5 purchases and 8 sales, worth an estimated $129K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: James B. Renacci sold $1,000 - $15,000 of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) on January 27, 2016. Since that trade, REGN is up +61.50% against the S&P 500 up +358.75%, an outperformance of -297.25%.
Across these filings, James B. Renacci has been a net seller of REGN (a buy-to-sell ratio of 0.63). The most recent disclosed REGN transaction shown was dated January 29, 2016. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
James B. Renacci's REGN trades vs the price
REGN is up +61.50% since James B. Renacci sold on January 27, 2016, versus +358.75% for the S&P 500.
Performance since this trade
All James B. Renacci REGN trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
James B. Renacci & REGN trading FAQ
Is it legal for James B. Renacci to trade Regeneron Pharmaceuticals Inc (REGN) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Regeneron Pharmaceuticals Inc (REGN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James B. Renacci sell REGN?
James B. Renacci disclosed a sale of $1,000 - $15,000 of Regeneron Pharmaceuticals Inc (REGN) on January 27, 2016, according to public STOCK Act filings.
How has REGN performed since James B. Renacci's trade?
Since James B. Renacci sold REGN on January 27, 2016, the stock is up +61.50%, versus +358.75% for the S&P 500 over the same period, an outperformance of -297.25%.
How many times has James B. Renacci traded REGN?
James B. Renacci has disclosed 13 REGN trades since 2015 (5 purchases and 8 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional REGN trades?
Quantellect tracks every disclosed congressional trade in Regeneron Pharmaceuticals Inc (REGN) on the Regeneron Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.
James B. Renacci's REGN tradesAll congressional filings for Regeneron Pharmaceuticals IncJames B. Renacci's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.